BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 25913254)

  • 1. Doxorubicin-loaded NaYF4:Yb/Tm-TiO2 inorganic photosensitizers for NIR-triggered photodynamic therapy and enhanced chemotherapy in drug-resistant breast cancers.
    Zeng L; Pan Y; Tian Y; Wang X; Ren W; Wang S; Lu G; Wu A
    Biomaterials; 2015 Jul; 57():93-106. PubMed ID: 25913254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for in vivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers.
    Zhang L; Zeng L; Pan Y; Luo S; Ren W; Gong A; Ma X; Liang H; Lu G; Wu A
    Biomaterials; 2015 Mar; 44():82-90. PubMed ID: 25617128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo targeted magnetic resonance imaging and visualized photodynamic therapy in deep-tissue cancers using folic acid-functionalized superparamagnetic-upconversion nanocomposites.
    Zeng L; Luo L; Pan Y; Luo S; Lu G; Wu A
    Nanoscale; 2015 May; 7(19):8946-54. PubMed ID: 25920333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 808 nm Light-triggered and hyaluronic acid-targeted dual-photosensitizers nanoplatform by fully utilizing Nd(3+)-sensitized upconversion emission with enhanced anti-tumor efficacy.
    Hou Z; Deng K; Li C; Deng X; Lian H; Cheng Z; Jin D; Lin J
    Biomaterials; 2016 Sep; 101():32-46. PubMed ID: 27267626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Janus upconverting nanoplatform with biodegradability for glutathione depletion, near-infrared light induced photodynamic therapy and accelerated excretion.
    Zhou H; Li Q; Cheng X; Zhang C; Sun J; Du L; Cao J; Liu Y; Huang P
    J Mater Chem B; 2020 Oct; 8(40):9251-9257. PubMed ID: 32929430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway.
    Hou Z; Zhang Y; Deng K; Chen Y; Li X; Deng X; Cheng Z; Lian H; Li C; Lin J
    ACS Nano; 2015 Mar; 9(3):2584-99. PubMed ID: 25692960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new NIR-triggered doxorubicin and photosensitizer indocyanine green co-delivery system for enhanced multidrug resistant cancer treatment through simultaneous chemo/photothermal/photodynamic therapy.
    Yu Y; Zhang Z; Wang Y; Zhu H; Li F; Shen Y; Guo S
    Acta Biomater; 2017 Sep; 59():170-180. PubMed ID: 28629893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-infrared light-mediated DOX-UCNPs@mHTiO
    Chen Y; Lin H; Tong R; An N; Qu F
    Colloids Surf B Biointerfaces; 2017 Jun; 154():429-437. PubMed ID: 28391106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-based upconversion nanocarriers with yolk-shell structure for dual-modal imaging and enhanced chemotherapy to overcome multidrug resistance in breast cancer.
    Pan Y; Zhang L; Zeng L; Ren W; Xiao X; Zhang J; Zhang L; Li A; Lu G; Wu A
    Nanoscale; 2016 Jan; 8(2):878-88. PubMed ID: 26648267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
    He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
    Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phthalocyanine-Conjugated Upconversion NaYF
    Kostiv U; Patsula V; Noculak A; Podhorodecki A; Větvička D; Poučková P; Sedláková Z; Horák D
    ChemMedChem; 2017 Dec; 12(24):2066-2073. PubMed ID: 29105372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoceria-Mediated Drug Delivery for Targeted Photodynamic Therapy on Drug-Resistant Breast Cancer.
    Li H; Liu C; Zeng YP; Hao YH; Huang JW; Yang ZY; Li R
    ACS Appl Mater Interfaces; 2016 Nov; 8(46):31510-31523. PubMed ID: 27933980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling trapping states on selective theranostic core@shell (NaYF
    Ramírez-García G; De la Rosa E; López-Luke T; Panikar SS; Salas P
    Dalton Trans; 2019 Jul; 48(27):9962-9973. PubMed ID: 31074748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles.
    Zhao N; Wu B; Hu X; Xing D
    Biomaterials; 2017 Oct; 141():40-49. PubMed ID: 28666101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
    Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
    Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional Fe3O4-TiO2 nanocomposites for magnetic resonance imaging and potential photodynamic therapy.
    Zeng L; Ren W; Xiang L; Zheng J; Chen B; Wu A
    Nanoscale; 2013 Mar; 5(5):2107-13. PubMed ID: 23381832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
    Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
    Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ROS-generating photosensitizer-free NaYF
    Kowalik P; Kamińska I; Fronc K; Borodziuk A; Duda M; Wojciechowski T; Sobczak K; Kalinowska D; Klepka MT; Sikora B
    Nanotechnology; 2021 Sep; 32(47):. PubMed ID: 33618335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.